ArticleClinical cancer research : an official journal of the American Association for Cancer Research2019

Phase I Study of Intermittent High-Dose Lapatinib Alternating with Capecitabine for HER2-Positive Breast Cancer Patients with Central Nervous System Metastases.

Aki Morikawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.